✦ LIBER ✦

122 A phase-II Trial of intermittent androgen ablation in patients presenting biochemical failure after definitive radiotherapy for localized prostate cancer

✍ Scribed by F. Cury; L. Souhami; R. Rajan; S. Tanguay; M. Duclos; G. Shenouda; B. Gagnon; S. Faria; M. David; C. Freeman

Book ID: 119516823
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 236 KB
Volume: 76
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(05)80283-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final results of the Canadian prospectiv

Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer : Clinical parameters

✍ Nicholas Bruchovsky; Laurence Klotz; Juanita Crook; Shawn Malone; Charles Ludgat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

A phase II trial of imatinib mesylate in

A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapy

✍ Amy M. Lin; Brian I. Rini; Vivian Weinberg; Kristen Fong; Charles J. Ryan; Jonat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Locally advanced prostate cancer: Bioche

Locally advanced prostate cancer: Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

✍ Bernardo Rocco; Epifanio Scardino; Ottavio de Cobelli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

I n the article by Bruchovsky et al., 1 intermittent androgen sup- pression was evaluated in patients with clinically locally advanced prostate cancer who developed biochemical disease recurrence after radiotherapy. We consider it to be of utmost important to improve currently existing knowledge re

Locally advanced prostate cancer—biochem

Locally advanced prostate cancer—biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

✍ Nicholas Bruchovsky; Laurence Klotz; Juanita Crook; S. Larry Goldenberg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Phase I-II prospective dose-escalating t

Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy

✍ Peter E. Clark; M. Craig Hall; Lester S. Borden Jr; Antonius A. Miller; Jennifer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Long-term Follow-up of a Phase II Trial

Long-term Follow-up of a Phase II Trial of Chemotherapy Plus Hormone Therapy for Biochemical Relapse After Definitive Local Therapy for Prostate Cancer

✍ Nakabayashi, Mari; Xie, Wanling; Buckle, Geoffrey; Bubley, Glenn; Ernstoff, Marc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 164 KB